Laserfiche WebLink
no data available <br />10.4 Conditions to avoid <br />no data available <br />10.5 Incompatible materials <br />Strong oxidizing agents <br />10.6 Hazardous decomposition products <br />Other decomposition products - no data available <br />11. TOXICOLOGICAL INFORMATION <br />11.1 Information on toxicological effects <br />Acute toxicity <br />LD50 Subcutaneous - mouse - 616 mg/kg <br />Skin corrosion/irritation <br />no data available <br />Serious eye damage/eye irritation <br />no data available <br />Respiratory or skin sensitization <br />no data available <br />Germ cell mutagenicity <br />no data available <br />Carcinogenicity <br />IARC: No component of this product present at levels greater than or equal to 0.1 % is identified as <br />probable, possible or confirmed human carcinogen by IARC. <br />Reproductive toxicity <br />no data available <br />Specific target organ toxicity - single exposure <br />Inhalation - May cause respiratory irritation. <br />Specific target organ toxicity - repeated exposure <br />no data available <br />Aspiration hazard <br />no data available <br />Potential health effects <br />Inhalation May be harmful if inhaled. Causes respiratory tract irritation. <br />Ingestion May be harmful if swallowed. <br />Skin Maybe harmful if absorbed through skin. Causes skin irritation. <br />Eyes Causes serious eye irritation. <br />Signs and Symptoms of Exposure <br />Men exposed to manganese dusts showed a decrease in fertility. Chronic manganese poisoning primarily <br />involves the central nervous system. Early symptoms include languor, sleepiness and weakness in the <br />legs. A stolid mask -like appearance of the face, emotional disturbances such as uncontrollable laughter <br />and a spastic gait with tendencyto fall in walking are findings in more advanced cases. High incidence of <br />pneumonia has been found in workers exposed to the dust or fume of some manganese compounds. <br />Additional Information <br />RTECS: OP0915000 <br />12. ECOLOGICAL INFORMATION <br />12.1 Toxicity <br />no data available <br />12.2 Persistence and degradability <br />no data available <br />12.3 Bioaccumulative potential <br />no data available <br />12.4 Mobility in soil <br />no data available <br />12.5 Results of PBT and vPvB assessment <br />no data available <br />12.6 Other adverse effects <br />no data available <br />13. DISPOSAL CONSIDERATIONS <br />